[FURL=https://www.industryarc.com/Report/16903/radioactive-diagnostic-agent-market.html?utm_source=briefingwire&utm_medium=pressrelease&utm_campaign=paidpressrelease]Radioactive Diagnostic Agent Market[/FURL] Radioactive Diagnostic Agent Market size is estimated to reach $1.6 billion by 2026, growing at a CAGR of 5.7% during the forecast period 2021-2026. Radioactive diagnostic agents are used in the determination of total plasma and blood volume. They are also used for the diagnosis of metastatic neuroblastoma. Radioactive diagnostic agents are extensively being used across the world owing to the rise in the importance of diagnosis for a specific defect in the body and the growing demand for radioactive agents in cancer therapy and tumor imaging.Key Takeaways
Geographically, the North America Radioactive Diagnostic Agent Market accounted for the highest revenue share in 2020, and it is poised to dominate over the period 2021-2026 owing to the rise in the demand for diagnostic X-rays in developed regions.
The increase in the adoption of cost-effective diagnostic agents in hospitals is driving the Hospitals segment. However, the short half-life of radiopharmaceuticals is one of the major factors that is said to reduce the growth of the Radioactive Diagnostic Agent Market.
Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Radioactive Diagnostic Agent Market report.
Download Sample Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=16903[/FURL]
Radioactive Diagnostic Agent Market Segment Analysis - By Geography
The Radioactive Diagnostic Agent Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and Rest of the World. North America held the largest share, with 35% of the overall market in 2020. The growth in this segment is owing to the factors such as the increasing demand for diagnostic X-rays in developed regions and the growing adoption of radiotracers for tumor imaging.
Radioactive Diagnostic Agent Market Drivers
Increase in the Focus on Developing Advanced Radioactive Diagnostic Agents is Expected to Boost Product Demand.
Rise in the Prevalence of Target Conditions will Provide New Growth Avenues to the Industry Growth.
Radioactive Diagnostic Agent Market Competitive Landscape:
Radioactive Diagnostic Agent Market. Key companies of this market are
GE Healthcare, Mallinckrodt Pharmaceuticals, Cardinal Health, Navidea Biopharmaceuticals, Curium Pharma, Advanced Accelerator Applications, Bracco Diagnostic Inc, Jazz Pharmaceuticals, Lantheus Medical Imaging, Inc, Eli Lilly and Company
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.